Current status of surgical treatment for hepatocellular carcinoma
- PMID: 11019487
Current status of surgical treatment for hepatocellular carcinoma
Abstract
The therapeutic modalities for hepatocellular carcinoma (HCC) have diversified during the past decades, and in particular, the treatment has mainly been concentrated on small HCC of 3 cm or less. Therefore, it has become very important for surgeons to be able to identify the clinical indications for liver resection in HCC. We reviewed data on liver resection for HCC using the National Primary Hepatic Cancer follow-up survey report of the Liver Cancer Study Group of Japan, indicating problem associated with liver resection for HCC. As a result, the indications of surgical treatment for HCC are as follows: (1) In patients with HCC of 3 cm or less in diameter, a solitary HCC indicates liver resection. However, priority should be given to medical treatment such as percutaneous transhepatic ethanol injection therapy, microwave coagulative necrosis therapy for multiple HCC and patients with clinical states II or III. (2) HCC between 3 cm and 5 cm in diameter is a good indicator for liver resection. Solitary HCC indicates liver resection as a first choice. (3) HCC greater than 5 cm diameter eter and cases with tumor stages II or III indicate liver resection. (4) There are limits to treating HCC with tumor thrombus in the second branch of the portal vein (Vp2) and tumor thrombus in the first branch, the trunk of the portal vein or in a branch on the opposite side (Vp3) only by liver resection. (5) HCC with tumor thrombus in the right, middle or left hepatic vein trunk, posterior inferior hepatic vein trunk or short hepatic vein (Vv2) and with tumor thrombus in the inferior vena cava (Vv3) are indicators for liver resection. A limited resection according to Glissons structure and with a negative surgical margin can be performed in HCC of 5 cm or less, however an extended resection is required for HCC greater than 5 cm. Furthermore, the extent of liver resection should be considered according to the hepatitis virus. Finally, it was emphasized that effective measures against the postoperative recurrence was essential in order to improve the outcome of HCC.
Similar articles
-
[Hepatic resection with removal of tumor thrombi for hepatocellular carcinoma with tumor thrombi in portal vein and curative analysis].Zhonghua Wai Ke Za Zhi. 1999 Jan;37(1):8-11. Zhonghua Wai Ke Za Zhi. 1999. PMID: 11829766 Chinese.
-
Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.Ann Surg Oncol. 2009 May;16(5):1254. doi: 10.1245/s10434-009-0383-y. Epub 2009 Mar 10. Ann Surg Oncol. 2009. PMID: 19277788
-
Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.Ann Surg Oncol. 2006 Jul;13(7):940-6. doi: 10.1245/ASO.2006.08.007. Epub 2006 May 23. Ann Surg Oncol. 2006. PMID: 16788755
-
Local injection therapy for hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):16-21. Hepatobiliary Pancreat Dis Int. 2006. PMID: 16481276 Review.
-
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.Liver Transpl. 2004 Feb;10(2 Suppl 1):S39-45. doi: 10.1002/lt.20040. Liver Transpl. 2004. PMID: 14762838 Review.
Cited by
-
Indocyanine green identification for tumor infiltration or metastasis originating from hepatocellular carcinoma.Int J Surg Case Rep. 2018;46:56-61. doi: 10.1016/j.ijscr.2018.03.044. Epub 2018 Apr 16. Int J Surg Case Rep. 2018. PMID: 29684806 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous